Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resilience Government Services is a specialized subsidiary of National Resilience, Inc., focused on providing biomanufacturing solutions and medical countermeasures for government agencies. Formerly known as Ology Bioservices, the company operates as a technology-focused CDMO that develops and manufactures complex medicines including biologics, vaccines, and nucleic acids. It holds significant contracts with the U.S. Department of Defense (DOD) and the Department of Health and Human Services (HHS) to bolster domestic supply chains and pandemic preparedness. The company leverages advanced manufacturing technologies to scale production of critical treatments for biological threats and infectious diseases. RGS is a key component of the broader Resilience network, which aims to modernize the global biopharmaceutical manufacturing ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Resilience Government Services.